“By combining Mr. Cooper and Rocket, we will form the strongest mortgage company in the industry, offering an end-to-end ...

API testing firm APIsec has confirmed it secured an exposed internal database containing customer data, which was connected ...

The abrupt resignation announcement that came late on Friday, March 28, from Peter Marks, who heads the U.S. FDA's Center for Biologics Evaluation and Research, has sent reverberations throughout the ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

The Ukrainian government has instigated rapid cost-cutting measures across the drug retail sector, triggered by reports of ...

Drugs from Novartis, Amgen and now Lilly have proven powerfully effective at reducing Lp(a). Whether that will translate to a ...

Tivoxavir marboxil's potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted animal models and positive Phase 1 data Ongoing FDA ...

In pharma, buying software (instead of building) means working with industry professionals who can develop solutions to meet ...

The interim results of a phase 3 trial of Merck’s pulmonary arterial hypertension (PAH) treatment Winrevair were so ...

Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are ...

Pharmaceutical companies fund most clinical research, shaping medical science to favor profit over patients. How does ...

Fintel reports that on March 31, 2025, Piper Sandler initiated coverage of Centessa Pharmaceuticals plc - Depositary Receipt () (NasdaqGS:CNTA) with a Overweight recommendation. Analyst Price ...